Practices / Mergers & Acquisitions
Public and private M&A, carve-outs, joint ventures, and cross-border deal structuring.
Our M&A practice handles the full lifecycle of corporate transactions — from term sheet to post-close integration. We act for public company boards, financial sponsors, founders, and multinational corporates. Recent mandates include cross-border carve-outs requiring antitrust clearance in five jurisdictions, and going-private transactions under accelerated timelines.
We are known for running deals quietly. The firm's conflict desk clears potential engagements within four business hours, and our partners stay on the file from signing through closing.
Acted for the seller on the carve-out of a global industrial subsidiary, coordinating antitrust filings in five jurisdictions and negotiating a complex transition services agreement.
Closed in 11 months with unconditional clearance in all five jurisdictions.
Acted for the special committee in the going-private transaction of a NYSE-listed industrial consolidator, navigating concurrent securities class action litigation.
Closed at $52 per share, a 38% premium to unaffected price.
Structured a 50/50 joint venture between two pharmaceutical majors to develop and commercialize a late-stage oncology pipeline.
JV agreement signed in 7 months; first drug approval expected in 2026.
Acted for a U.S. pharma acquirer on the acquisition of an Asia-based target, with concurrent IP and tax structuring across seven jurisdictions.
Closed with full step-up in basis and IP ownership consolidated in holding company.